Development of a Natural Model of Cutaneous  Leishmaniasis: Powerful Effects of  Vector Saliva and Saliva Preexposure on the Long-Term Outcome of Leishmania major Infection in the Mouse Ear Dermis by Belkaid, Yasmine et al.
 
1941
 
The Journal of Experimental Medicine • Volume 188, Number 10, November 16, 1998 1941–1953
http://www.jem.org
 
Development of a Natural Model of Cutaneous 
Leishmaniasis: Powerful Effects of Vector Saliva and
Saliva Preexposure on the Long-Term Outcome of
 
Leishmania major 
 
Infection in the Mouse Ear Dermis
 
By Yasmine Belkaid,
 
*
 
 Shaden Kamhawi,
 
*
 
 Govind Modi,
 
*
 
Jesus Valenzuela,
 
*
 
 Nancy Noben-Trauth,
 
‡
 
 Edgar Rowton,
 
§
 
José Ribeiro,
 
*
 
 and David L. Sacks
 
*
 
From the 
 
*
 
Laboratory of Parasitic Diseases and the 
 
‡
 
Laboratory of Immunology, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and the 
 
§
 
Department of Entomology, Walter Reed Army Institute of Research, Washington DC 20307
 
Summary
 
We have developed a model of cutaneous leishmaniasis due to 
 
Leishmania major
 
 that seeks to
mimic the natural conditions of infection. 1,000 metacyclic promastigotes were coinoculated
with a salivary gland sonicate (SGS) obtained from a natural vector, 
 
Phlebotomus papatasii
 
, into
the ear dermis of naive mice or of mice preexposed to SGS. The studies reveal a dramatic exac-
erbating effect of SGS on lesion development in the dermal site, and a complete abrogation of
this effect in mice preexposed to salivary components. In both BALB/c and C57Bl/6 (B/6)
mice, the dermal lesions appeared earlier, were more destructive, and contained greater num-
bers of parasites after infection in the presence of SGS. Furthermore, coinoculation of SGS
converted B/6 mice into a nonhealing phenotype. No effect of SGS was seen in either IL-4–
deficient or in SCID mice. Disease exacerbation in both BALB/c and B/6 mice was associated
with an early (6 h) increase in the frequency of epidermal cells producing type 2 cytokines.
SGS did not elicit type 2 cytokines in the epidermis of mice previously injected with SGS.
These mice made antisaliva antibodies that were able to neutralize the ability of SGS to en-
hance infection and to elicit IL-4 and IL-5 responses in the epidermis. These results are the first
to suggest that for individuals at risk of vector-borne infections, history of exposure to vector
saliva might influence the outcome of exposure to transmitted parasites.
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E
 
xperimental models of leishmaniasis have only rarely
attempted to reproduce the biology of natural trans-
 
mission, including a consideration of (
 
a
 
) dose—sand flies
inoculate low numbers of parasites, variably estimated at
10–1,000 metacyclic promastigotes (1); (
 
b
 
) saliva—parasites
are coinoculated with small amounts of sand fly saliva that
contain antihemostatic (2) and potentially immunomodula-
tory (3, 4) molecules that facilitate blood feeding; and (
 
c
 
)
site of inoculation—infection is initiated in the skin, which
is organized as specialized dermal and epidermal compart-
ments containing unique cells such as keratinocytes, den-
dritic epidermal T cells (DETC),
 
1
 
 and Langerhans’ cells
that enable it to deal with the hostile external environment
to which it is frequently exposed (5). When attention has
been paid to one or more of these variables, exceptional
outcomes have been observed. With respect to dose, infec-
tion with 100–1,000 parasites, as opposed to the more usual
experimental dose range of 10
 
5
 
–10
 
7
 
, has been reported to
convert genetically susceptible BALB/c mice to a resistant
phenotype (6, 7). The discovery that small amounts of sand
fly saliva could enhance infection when coinoculated with
 
Leishmania
 
 promastigotes (8) was the first to formally inval-
idate the notion that bloodsucking arthropod vectors are
merely “flying syringes.” So far as we are aware, there is
only a single published report in which the outcome of cu-
taneous leishmaniasis initiated in a strictly dermal site has
been described (9). In this study, the lesions in BALB/c
mice inoculated intradermally versus subcutaneously at the
base of the tail were contained in the former and progres-
 
1
 
Abbreviations used in this paper:
 
 DETC, dendritic epidermal T cells; DTH,
delayed type hypersensitivity; SGS, salivary gland sonicate; SLA, soluble
 
L. major
 
 antigen.
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sive in the later. While 
 
L. major
 
 infection has also been ini-
tiated in the ear dermis, this site was primarily used to study
the interaction of 
 
Leishmania
 
 and dendritic cells (10). Only
recently has the ear dermis been used to follow actual le-
sion development and immune response (Belkaid, Y., M.
Lebastard, V. Leclercq, and G. Milon, manuscript submit-
ted for publication). Finally, one potentially important as-
pect of natural transmission has never been addressed, so far
as we are aware; individuals who live in endemic areas will
generally be exposed to the bites of uninfected sand flies
before the bite that transmits infection. The possibility that
preexposure to vector saliva might modulate infection has
not been explored.
This report describes a model of cutaneous leishmaniasis
that takes into account each of these conditions of natural
infection. It describes the outcome of cutaneous leishman-
iasis in BALB/c and C57Bl/6 (B/6) mice inoculated with
low numbers of metacyclic promastigotes, with and with-
out salivary gland sonicate (SGS), into the ear dermis of
both naive mice and mice previously exposed to SGS. The
skin, in addition to being the natural site of parasite and sa-
liva deposition, offers the advantage that the lymphomye-
loid cells within the inflammatory dermal and epidermal
compartments can be recovered, enumerated, and identi-
fied (11). In these studies, the function of these cells with
respect to cytokine response was characterized for the first
time at the single cell level using intracellular staining in
combination with flow cytometry. The data reveal a dra-
matic effect of salivary components on the course and se-
verity of 
 
L. major
 
 infection in the ear dermis that is associ-
ated with a rapid increase in the frequency of epidermal
cells producing type 2 cytokines, and a complete reversal of
these effects due to the presence of antisaliva antibodies in
mice preexposed to SGS.
 
Materials and Methods
 
Mice.
 
Female 8–12-wk-old, BALB/c, C57Bl/6N (B/6) mice
were purchased from the National Cancer Institute, Department
of Cancer Treatment (Frederick, MD). The IL-4–deficient
BALB/c and C57Bl/6 mice were generated from either BALB/c
or C57Bl/6 embryonic stem cell lines (12, 13). IL-12p40 
 
2
 
/
 
2
 
mice on the C57Bl/6 genetic background were generated by
Magram et al. (14) and were provided by B. Kelsall and S. Guru-
nathan (National Institute of Allergy and Infectious Diseases
[NIAID], Bethesda, MD). SCID mice (C.B.17 
 
scid
 
/
 
scid
 
, H-2d)
were provided by K. Tirumalai (NIAID). All mice were kept in
the NIAID animal care facility under pathogen-free conditions.
 
Parasite. L. major
 
 clone V1 (MHOM/IL/80/Friedlin) was
cultured in medium 199 supplemented with 20% HI-FCS (Hy-
clone, Logan, UT), 100 U/ml penicillin, 100 
 
m
 
g/ml streptomy-
cin, 2 mM l-glutamine, 40 mM Hepes, 0.1 mM adenine (in 50
mM Hepes), 5 mg/ml hemin (in 50% triethanolamine), and 1
mg/ml 6-biotin (M199/S). Infective stage metacyclic promasti-
gotes of 
 
L. major
 
 were isolated from stationary culture (5–6-d old)
by negative selection using peanut agglutinin (Vector Laborato-
ries Inc., Burlingame, CA).
 
Sand Fly Salivary Glands.
 
SGS were prepared from 7–10-
d-old laboratory-bred, female 
 
P. papatasii
 
 isolated from the Jordan
Valley (Israel) as described previously (8). Briefly, 20 pairs of sali-
vary glands were dissected, placed in 20 
 
m
 
l of ice cold Hepes
buffer, and stored at 
 
2
 
70
 
8
 
C. Immediately before use, the glands
were sonicated, microfuged at 8,000 
 
g
 
, and the supernatant was
collected. Protein was quantified using the BCA protein assay re-
agent A (Pierce Chemical Co., Rockford, IL) and comprised 2–3
 
m
 
g per pair.
 
Intradermal Infection and Sensitization.
 
1,000 metacyclic 
 
L. ma-
jor
 
 promastigotes with or without 0.2 pair of SGS were inocu-
lated intradermally into the ear dermis using a 27.5 G needle in a
volume of 10 
 
m
 
l PBS. Some mice were injected intradermally in
one ear two times with 0.2 pair of SGS at 2-wk intervals, and
challenged in the opposite ear 2 wk after the last injection. The
evolution of the infection was monitored by measuring the diam-
eter of the induration of the ear lesion with a direct reading ver-
nier caliper.
 
Quantification of Parasites.
 
The two dermal sheets of the in-
fected ears were separated, deposited dermal side down in
DMEM containing 100 U/ml penicillin, 100 
 
m
 
g/ml streptomy-
cin, 1 mg/ml collagenase A (Sigma Chemical Co., St. Louis,
MO), and incubated for 2 h at 37
 
8
 
C. The dermal sheets were
then homogenized using a Teflon-coated microtissue grinder in a
microfuge tube containing 100 
 
m
 
l of M199/S. The tissue homog-
enates were serially diluted in 96-well flat bottom microtiter
plates containing biphasic medium prepared using 50 
 
m
 
l NNN
medium with 30% of defibrinated rabbit blood and overlaid with
50 
 
m
 
l M199/S. The number of viable parasites in each tissue was
determined from the highest dilution at which promastigotes
could be grown out after up to 7 d of incubation at 26
 
8
 
C.
 
Analysis of the Inflammatory Dermal Site.
 
The cells in the in-
flammatory ear dermis were recovered as described previously
(11). Briefly, at different time points after intradermal inoculation
the ears were collected, rinsed in 70% ethanol with vigorous
shaking, and allowed to dry. Using a pair of fine forceps, the ven-
tral and dorsal dermal sheets were separated and immediately pro-
cessed. The two leaflets were transferred on culture medium der-
mal side down into a 6-well plate (non–tissue culture-treated;
Greiner Labortechnik, Kremsmuenster, Austria) for 6 h. Each
well contained 4 ml of RPMI 1640, NaHCO
 
3
 
 with 25 mM
Hepes, 10% HIFBS and penicillin/streptomycin. The cell popu-
lations spontaneously emigrating out of the dermal layers, con-
taining nonadherent and loosely adherent cells, were pooled. The
loosely adherent cells were recovered by further incubation for
20 min at 37
 
8
 
C in PBS without calcium and magnesium, contain-
ing 2 mg/ml glucose. The pooled cells were filtered through a
70-
 
m
 
m nylon cell strainer (Becton Dickinson, Mountain View,
CA) and washed twice in HBSS without phenol red.
 
Epidermal Cell Preparation.
 
At different time points after intra-
dermal inoculation, mice were killed and their ears were col-
lected. The ears were rinsed in 70% ethanol with vigorous shak-
ing and allowed to dry. Using a pair of fine forceps, the ventral
and dorsal dermal sheets were separated and transferred dermal
side down on DMEM-penicillin/streptomycin with 0.5% trypsin
(USB Biologicals, Cleveland, OH) for the dorsal face and 1%
trypsin for the ventral face. The sheets were incubated for 30 min
at 37
 
8
 
C. The epidermal cells were recovered as described previ-
ously (15) with modifications. In brief, the epidermis was sepa-
rated from the dermis and deposited on a 70-
 
m
 
m nylon cell
strainer (Becton Dickinson), which was placed in a petri dish
containing DMEM plus 20% FBS, 100 U/ml penicillin, 100 
 
m
 
g/ml
streptomycin, and 0.05% DNase (Sigma Chemical Co.). The fil-
ter was shaken gently for 2 min, the cells passing through the fil-
ter were washed, and 3 
 
3
 
 10
 
6
 
 cells in 5 ml were distributed in 
1943
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6-well plates. After incubation at 37
 
8
 
C for 6 h in the presence of
10 
 
m
 
g/ml Brefeldin A (Sigma Chemical Co.), the cells were col-
lected, fixed with 4% paraformaldehyde in PBS for 20 min, and
washed with cold PBS containing 0.1% BSA before staining.
 
Immunolabeling and Flow Cytometry.
 
Each labeling was car-
ried out on 10
 
6
 
 cells for 30 min on ice in a 100 
 
m
 
l volume in U
bottom 96-well microtiter plates. The dermal cells were incu-
bated with 10% normal mouse serum in PBS containing 0.1%
BSA and 0.01% NaN
 
3
 
 before being incubated with anti-Fc re-
ceptor antibody (2.4G2; PharMingen Co., San Diego, CA). The
double staining was done by using directly conjugated antibodies
incubated simultaneously. The dermal inflammatory cells were
identified by characteristic size (FSC) and granulosity (SSC) com-
bined with two-color analysis, as described previously (11).
Briefly, the dendritic leukocytes were identified as large cells,
MHC class II (25-9-17; PharMingen) bright, and F4/80 positive
(A3-1; Caltag Lab, Burlingame, CA). The mononuclear phago-
cytes were identified as F4/80 positive and MHC class II low or
negative. The neutrophils were identified as small cells, Ly-6G
bright (RB6-8C5; PharMingen), and negative for F4/80 (or
MHC class II); the eosinophils by their granulosity associated
with F4/80 lightly positive and MHC class II negative. The CD4
lymphocytes were identified by their small size and by CD4
(RM4-5; PharMingen) and CD3 (145-2C11; PharMingen) ex-
pression. The isotype controls used were rat IgG2b (A95-1;
PharMingen) and rat IgG2a (R35-95; PharMingen). After stain-
ing, the cells were fixed again with 1% paraformaldehyde and
washed. For each sample, 10
 
4
 
 cells were analyzed. Each sample
was cytospun in parallel and stained with Diff-Quik solution
(Dade Behring Inc., Düdingen, Switzerland); the percentages of
neutrophils, eosinophils, and mononuclear phagocytes estimated
by microscopic examination of stained cells were similar to those
obtained by flow cytometry.
For surface staining of epidermal cells, the cells were incu-
bated, after trypsin treatment, in complete DMEM overnight to
allow reexpression of surface markers, and identified as either 
 
gd
 
T cells by staining with anti-
 
gd
 
 T cell receptor antibody (GL3;
PharMingen), or as Langerhans’ cells by two-color staining using
anti–MHC class II (25-9-17; PharMingen) and anti-B7.1 (1G10;
PharMingen). For intracellular staining of cytokines, the fixed
epidermal cells were washed twice with cold PBS-BSA 0.1%,
then incubated with anti-Fc receptor antibody in PBS containing
10% normal mouse serum, 0.1% saponin (Fisher Scientific Co.,
Pittsburgh, PA), 0.1% BSA, 1 mM CaCl, 1 mM MgSO
 
4
 
, and 40
mM Hepes (permeabilization buffer). After washing, the cells
were incubated with the anticytokine antibodies and their corre-
sponding isotype control. All of the anticytokine antibodies were
obtained from PharMingen and were directly conjugated to R-PE:
anti–TNF-
 
a
 
, (MP6-XT22), anti–IL-3 (MP2-8F8), anti–IL-5
(TRFK5), anti–IL-6 (MP5-20F3), anti–IL-12 (C15.6), anti–IFN-
 
g
 
(XMG1.2), and isotype control, rat IgG1 (R3-34); anti–IL-2
(JE56-5H4), anti–IL-4 (BVD4-1D11), anti–IL-10, (JES5-16E3),
and their isotype control, rat IgG2b (R35-38); anti–GM-CSF-PE
(PI-22E9) and its isotype control, rat IgG2a (R35-95), anti–
MCP-1 (2H5), and its isotype control hamster IgG (G235-2356).
After staining, the cells were fixed again with 1% paraformalde-
hyde and washed. For each sample, 2 
 
3
 
 10
 
4
 
 cells were analyzed.
The data were collected and analyzed using CELLQuest
 
Ô
 
 soft-
ware and a FACScalibur
 
Ò
 
 flow cytometer (Becton Dickinson Im-
munocytometry System, San Jose, CA).
 
Lymphocyte Culture and Cytokine Assays.
 
For measurement of
in vitro cytokine production, single-cell suspensions of retromax-
illar lymph nodes draining the infected ears were prepared asepti-
cally at various times after infection. The cells were diluted to 8 
 
3
 
10
 
6
 
 cells/ml, and dispensed into 96-well plates without antigen or
with soluble 
 
L. major
 
 antigen (SLA) (25 
 
m
 
g/ml) or Con A (10
 
m
 
g/ml) in 100 
 
m
 
l of complete RPMI containing 0.05 mM 
 
b
 
-mer-
captoethanol. Cultures were incubated at 37
 
8
 
C in 5% CO
 
2
 
. Su-
pernatant fluids were harvested at 72 h and assayed for IL-4 and
IFN-
 
g
 
 by ELISA as described previously (16).
 
Analysis of Antisaliva Antibodies by ELISA and Western Blot-
ting.
 
The IgG fraction of control mouse serum and serum from
mice injected intradermally twice with SGS were purified by Im-
munopure Plus (A) IgG purification kit (Pierce Chemical Co.).
The presence of antisaliva antibodies in the IgG fraction or in
whole sera was determined by ELISA. 96-well microplates were
coated overnight at 4
 
8
 
C with 50 
 
m
 
l SGS diluted to 10 pair/ml in
the coating buffer (0.1 M Na
 
2
 
HCO
 
3
 
). After washing with PBS-
Tween, and saturation with PBS-FBS 20%, serial dilutions of sera
from control or immunized mice were incubated overnight at
4
 
8
 
C. After washing, plates were incubated with peroxidase-con-
jugated goat anti–mouse IgG (heavy and light chain specific) anti-
body in PBS-BSA 1%, followed by TMB peroxidase substrate
(Kirkegaard and Perry Laboratories Inc., Gaithersburg, MD). The
absorbance was recorded at 405 nm. Western blotting was per-
formed by electrophoresis of SGS (1 gland per lane) under reduc-
ing conditions. After transfer to nitrocellulose using the Novex
Xcell Blot II module (Novex, San Diego, CA) the membranes
were cut into strips, blocked with 5% dried skim milk in PBS-
0.05% Tween 20 for 1 h at room temperature, then incubated
with serum (1:200 dilution) in blocking buffer for 1 h, followed
by the anti–mouse IgG peroxidase conjugate (1:1,000). Bands
were visualized using the TMB membrane peroxidase substrate
(Kirkegaard and Perry Laboratories Inc.).
 
Results
 
Effect of Sand Fly Saliva on the Course of L. major Infection
in the Mouse Ear Dermis.
 
It has been shown previously
that the coinoculation of sand fly saliva with 
 
L. major
 
 into
the mouse footpad increases the infectivity of the parasite
(8, 17–19). We attempted to extend these observations us-
ing a more physiologic model of infection in which a low
number (1,000) of 
 
L. major
 
 metacyclics promastigotes was
inoculated into the ear dermis with or without 0.2 pair of
SGS. In BALB/c mice infected with parasites alone (Fig. 1
 
A
 
), the dermal lesions were first detectable around week 4;
they increased slowly in size, accompanied by ulceration
and tissue necrosis after 2–3 mo (Fig. 2 
 
A
 
). The lesions
continued to progress for up to 7 mo, at which time exten-
sive necrosis and dermal erosion were observed. In con-
trast, the lesions in the B6 mice initiated using parasites
alone appeared around week 4, peaked in size at 7 wk, then
began to resolve so that by 10 wk only a small degree of in-
duration (
 
,
 
1 mm) was measurable, persisting for up to 7
mo (Fig. 1 
 
B
 
). Even the maximum size lesions in B/6 mice
remained nonulcerative and nonnecrotic (Fig. 2 
 
A). Thus
the genetically controlled nonhealing and healing pheno-
types of BALB/c and B/6 mice, respectively established us-
ing higher numbers of parasites inoculated in a subcutane-
ous site, are maintained in a dermal model using 1,000
metacyclic promastigotes. When the same number of para-
sites was coinoculated with 0.2 pair SGS from P. papatasii,1944 Natural Model of Cutaneous Leishmaniasis
the sizes of the lesions in both mouse strains were signifi-
cantly larger (P , 0.01) at virtually all time points examined,
beginning at 3 wk for BALB/c and at 2 wk for B/6 mice.
The dermal lesions in BALB/c mice appeared 1–2 wk ear-
lier, expanded rapidly for the first 4 wk, then progressed at
a slower rate until they began to ulcerate and necrose by 6–8
wk (Fig. 2 B). By 12 wk extensive dermal erosion had oc-
curred. For B/6 mice, the dermal lesions progressed to ap-
proximately three times the maximum size seen in the con-
trols, they became ulcerative and necrotic (Fig. 2 B), and
while their growth after 7 wk appeared to be contained,
the lesions did not diminish in size or severity for up to 8
mo after infection.
The size of the dermal lesions correlated well with num-
bers of viable parasites contained within the dermal site.
When evaluated 8 wk after infection, BALB/c and B/6
mice coinoculated with SGS had a 1,000- and a 100-fold
increase, respectively, in the number of lesion amastigotes
(Table 1). The table also includes the dermal parasite quan-
titation of B/6 mice 8 mo after infection, in which the
mice treated with SGS still had a 100-fold increase in the
number of lesion amastigotes compared with mice infected
with parasites alone. It is important to note that even the
control mice continued to harbor parasites in the skin.
The influence of SGS on the outcome of L. major infec-
tion was reflected in the levels of L. major–specific IFN-g
and IL-4 produced in vitro by cells from the draining
lymph node 8 wk after infection (Table 2). In control
mice, the amount of IL-4 produced by lymph node cells
from BALB/c mice was roughly 10-fold higher than B/6,
consistent with the nonhealing status of BALB/c mice after
infection in the dermal site. These levels of IL-4 were in-
creased by 1.5- and 3-fold, respectively, in BALB/c and B/6
mice infected in the presence of saliva. The IFN-g re-
sponse of SGS coinoculated B/6 mice was also significantly
reduced. Thus, vector saliva shifted the adaptive immune
response in the direction of Th2 responsiveness in both
BALB/c and B/6 mice.
The Effect of Preexposure to SGS on the Course of L. major
Infection in the Mouse Ear Dermis. Because of the likeli-
hood that individuals who are at risk of L. major infection
are preexposed to the bites of uninfected sand flies, we in-
vestigated whether this exposure might modify the host re-
sponse to parasites plus SGS. Mice were sensitized twice,
2 wk apart, by intradermal inoculation in the left ear using
the equivalent of 0.2 pair of SGS prepared from 10-d-old
sand flies. They were challenged in the right ear 2 wk later
with parasites plus SGS. As shown in Fig. 1, preexposure to
SGS completely abrogated the effect of the saliva on the
size of dermal lesions for both BALB/c and B/6 mice. In
each case, the SGS-sensitized mice behaved like the control
mice injected with parasites alone in terms of lesion size
and tissue pathology. Their tissue parasite loads at 8 wk
were reduced z100-fold compared with SGS naive mice
infected in the presence of saliva (Table 1). Finally, the ab-
rogation of the salivary effect on infection was associated
Figure 1. Size of induration of the ear lesion for (A) BALB/c or (B)
C57BL/6 mice after intradermal inoculation of 1,000 L. major metacyclic
promastigotes alone (s) or with 0.2 pair of SGS to naive mice (d) or to
SGS presensitized mice (j). Mean induration in mm 6 1 SD, 8–10 mice
per group.
Figure 2. Photomicrograph of BALB/c or C57BL/6 ears 10 wk after
intradermal inoculation of 1,000 L. major metacyclic promastigotes alone
(A), or with 0.2 pair of SGS to naive (B), or to SGS presensitized mice (C).1945 Belkaid et al.
with a reduced level of L. major–specific IL-4 production
by lymph node cells 8 wk after infection (Table 2). In fact,
for both BALB/c and B/6 mice, the IL-4 produced was
less than even control mice infected in the absence of SGS.
The IFN-g response in SGS-sensitized BALB/c mice was
also significantly reduced, although the ratio of IFN-g and
IL-4 still indicated a shift toward Th1 responsiveness in
these mice compared with the response observed in the
SGS naive animals after parasite delivery in the presence of
saliva.
Analysis of the Early Dermal and Epidermal Reactivity after
Challenge in Naive Mice and in Mice Sensitized to SGS.
The mechanism by which vector saliva enhances leishma-
nial infection remains to be clarified. One possibility that
has not been addressed previously is that the antihemostatic
activities of saliva promote cellular recruitment into the
skin, including mononuclear phagocytes, allowing a higher
proportion of parasites to find appropriate cells for infection
within the inoculation site. Since the dermis is the site of
cellular recruitment into the skin, which can occur from
blood and the overlying epidermis, we analyzed the leuko-
cyte trafficking within the dermis after intradermal inocula-
tion of the parasite alone or in the presence of SGS at 2, 4,
6, 12, 18, and 48 h after injection. The cells emigrating
from the L. major–loaded dermis were recovered and iden-
tified by flow cytometry using a combination of antibodies,
as described previously (11). The number of red blood cells
present in the dermis was approximately five times higher
in ears coinoculated with saliva. Surprisingly, when the
numbers of leukocytes were compared, no significant dif-
ference between the control ears and the SGS coinoculated
ears was seen during any of the early time points examined
(Fig. 3, A and B). Even when the dermal sheets were
treated with collagenase to recover immobilized cells, there
was no indication that SGS elicited an influx of leukocytes
into the dermis (data not shown). By comparison, in the
mice preexposed to SGS, the dermal inflammatory re-
sponse to parasites plus SGS was significantly altered. The
number of leukocytes recruited into the dermis at 18 h was
four- to fivefold greater, and was composed mainly of
mononuclear phagocytes, eosinophils, and neutrophils in
BALB/c mice, and of mononuclear phagocytes and eo-
sinophils in B/6 mice. The kinetics of this response, with
an accumulation of mononuclear phagocytes and eosino-
phils beginning at 6 h and peaking at 48 h, plus the fact that
this response was abrogated after in vivo depletion of
CD41 cells using GK1.5 antibody (data not shown), indi-
cated a delayed type hypersensitivity (DTH) response to
salivary components in SGS-sensitized mice. The influx of
both mononuclear phagocytes and eosinophils suggests that
this response is not especially polarized in terms of the
CD41 subsets that mediate the DTH.
The first line of defense of the body is the epidermis,
which in the mouse contains three major reactive cell pop-
Table 1. Effect of SGS and SGS Presensitization on the Number of Tissue Amastigotes in Mouse Ears 8 wk or 8 mo after Infection
L. major L. major 1 SGS L. major 1 SGS-sensitized mice
BALB/c 8 wk 1.3 3 103 6 4.2 3 102 *1.2 3 106 6 1.1 3 105 9.8 3 103 6 7.5 3 102
C57BL/6 8 wk 1.4 3 103 6 6.2 3 102 *1.2 3 105 6 2.3 3 104 1.6 3 103 6 5.1 3 102
C57BL/6 8 mo 3.8 3 102 6 1.5 3 102‡ 1.4 3 104 6 1.7 3 103 1.6 3 103 6 4.3 3 102
Values are mean number of amastigotes per ear 6 1 SD, 8 ears per group.
Values are significantly greater (*P , 0.001 and ‡P , 0.05) than the parasite numbers in the two other groups.
Table 2. Effect of SGS and SGS Presensitization on Leishmania–specific Cytokine Production by Lymph Node Cells Draining the Ear 8 wk 
after Infection
L. major L. major 1 SGS L. major 1 SGS-sensitized mice
IL-4 IFN-g IL-4 IFN-g IL-4 IFN-g
pg/ml pg/ml pg/ml pg/ml pg/ml pg/ml
BALB/c 2,942 6 215* 8,981 6 925 ‡4,263 6 620 6,937 6 850 544 6 155 2,510 6 620
C57BL/6 172  6 49 7,896 6 850 ‡529 6 133 §3,127 6 666 100 6 66 8,999 6 450
*Mean cytokine concentration 6 1 SD produced by lymph node cells (four lymph nodes per group) assayed 72 h after stimulation with 25 mg/ml SLA.
‡Significantly greater than the IL-4 produced by cells of the same mouse strain in the two other groups; P , 0.01.
§Significantly less than the IFN-g produced by cells of the same mouse strain in the two other groups; P , 0.02.1946 Natural Model of Cutaneous Leishmaniasis
ulations: keratinocytes, DETC, and Langerhans’ cells. The
number of epidermal cells recovered was high (z2.5 3 106
cells/ear for BALB/c and 2.9 3 106 cells/ear for B/6). Ap-
proximately 5–7% of the cells stained bright using anti-gd
T cell receptor antibody, and 5–10% were Langerhans’
cells, based on their strong dual staining with anti–MHC
class II and anti-B7.1 (data not shown). The remaining
cells, presumably keratinocytes, were not distinguishable by
surface staining. Each of these populations secretes a dis-
tinct set of cytokines (20), which we attempted to analyze
at the single cell level by intracellular staining and flow cy-
tometry. The epidermal cells were collected 6 h after inoc-
ulation and incubated overnight in the presence of Brefel-
din A to allow intracellular accumulation of produced
cytokines. The frequency of cells staining positive for each
cytokine was determined by two-color analysis of cells sin-
gly stained with PE-conjugated anticytokine antibody to
compensate for the considerable autofluorescence that is
characteristic of the epidermal cells. The steady state fre-
quencies of cytokine-positive cells were determined using
epidermal cells recovered from uninjected ears. Of these,
only a small proportion stained positive for IL-5 (0.5% for
BALB/c) or IL-3 (0.7% for BALB/c and 0.9% for B/6,
data not shown). The steady state cells were negative for
the remainder of the cytokines examined. Fig. 4 shows the
dot plot analyses from one of two separate experiments in
which a complete analysis of eight different cytokines was
carried out, showing the frequency of epidermal cells pro-
ducing each of the cytokines after intradermal injection of
PBS, 1,000 metacyclic promastigotes, or metacyclics plus
SGS. The needle injection of 10 ml of PBS induced pro-
duction of cytokines in response to tissue injury: primarily
IL-5, IL-3, TNF-a, and IFN-g. The especially strong
TNF-a response produced by B/6 mice was observed in
both experiments, as was the small increase in the frequency
of epidermal cells producing IFN-g and MCP-1. Whereas
the strong TNF-a response in BALB/c seemed to be in-
duced by the parasites, this was not observed in each analysis,
and it is more likely that in this experiment we failed to de-
tect the TNF-a made in response to the control needle in-
jection. Changes in the frequency of cells producing the
other cytokines examined were not observed. When the
parasite was inoculated with 0.2 pair SGS, there was an in-
crease in the frequency of epidermal cells producing Th2 cy-
tokines, including IL-4 (1.9%), IL-5 (8.4%), and GM-CSF
(1.6%) for BALB/c, and IL-4 (4.3%) and IL-5 (5.5%) for B/6
mice. The effect of SGS preexposure was to virtually elimi-
nate the early IL-4 response in the epidermis after injection
of parasites plus SGS (1.9 vs. 0.1% in BALB/c mice; 4.3 vs.
0.7% in B/6 mice). In BALB/c mice, the frequencies of cells
staining for IL-5 and GM-CSF were also reduced in SGS-
sensitized mice. These results indicate that SGS induces rapid
production of type 2 cytokines by epidermal cells, and that
prior exposure to SGS abolishes this host response.
In Fig. 5, the data from the flow analyses for the two ex-
periments were replotted in order to compare the absolute
number of cytokine producing cells per epidermis. Only
the data for IL-4, IL-5, and GM-CSF are shown, since
these were the only cytokines affected by coinoculation of
SGS. Considering the large number of epidermal cells re-
covered per ear, the absolute number of cells producing
these cytokines in response to SGS is remarkably high (e.g.,
1.24–1.88 3 105 cells/ear producing IL-4 in B/6 mice).
The inability of SGS to elicit these responses in SGS pre-
sensitized animals is clear; for BALB/c mice the numbers of
IL-4, IL-5, and GM-CSF producing cells in the two exper-
iments were reduced by 94 or 98%, 56 or 58%, and 94 or
96%, respectively, whereas for B/6 mice the number of
IL-4–producing cells was reduced by 89 or 82%, and the
IL-5 response appeared unaffected.
Effect of SGS on the Course of L. major Infection in IL-4–
deficient, IL-12p40–deficient, and SCID mice. The ability of
SGS to elicit an early type 2 response in the epidermis, in
association with its ability to exacerbate disease, led us to
investigate the effect of SGS on disease exacerbation in IL-4–
deficient mice. While IL-4 deletion can itself, depending
on the dose and strain of L. major used, convert BALB/c
mice into a more resistant phenotype (21), the develop-
ment of nonhealing dermal lesions initiated with 1,000
Friedlin strain metacyclics was unaffected by the IL-4 defi-
ciency in BALB/c mice (Fig. 6 A). However, the IL-4 de-
Figure 3. Leukocytes present in the dermal compartment after intra-
dermal inoculation of L. major into the ear of (A) BALB/c or (B) C57BL/6
mice. Mice were injected with 1,000 of L. major metacyclic promastigotes
alone or with 0.2 pair of SGS to naive or to SGS presensitized mice. The
ears were processed 18 h after inoculation, the cells obtained from four to
five ears per group were pooled, and the different populations of leuko-
cytes were identified by staining and flow cytometry as described in Ma-
terials and Methods. The data shown are the mean 6 1 SD of three sepa-
rate experiments. *Values significantly greater (P , 0.001) than the values
in the comparable cell populations of the two other groups.1947 Belkaid et al.
ficiency did eliminate any effect of SGS on disease exacer-
bation in these mice. In IL-4–deficient B/6 mice, SGS
produced a slight enhancement of lesion size during the
early stage of development, but the effect was much less
than that observed in the wild-type mice, which again de-
veloped large, nonhealing, necrotic dermal lesions (Fig. 7).
Thus, on both L. major–susceptible and –resistant genetic
backgrounds, IL-4 deficiency abrogates the ability of SGS
to promote infection in a dermal site. In contrast, dermal
infections in IL-12p40 knockout B/6 mice, which as ex-
pected were nonhealing and uncontrolled even when in-
fected with parasites alone, were exacerbated even further
by the inclusion of SGS in the inoculum (Fig. 7). Whereas
in the absence of SGS the dermal lesions first appeared in
the IL-12p40 knockout mice at week 5 and progressed rap-
idly with extensive dermal erosion present at week 10, in
the SGS coinoculated IL-12p40 knockout mice, each of
these events were advanced by 3–4 wk. Lastly, the ability
of SGS to exacerbate infection was investigated in SCID
mice. Lesion appearance was delayed until week 10 for
mice infected with or without SGS, after which the devel-
opment of progressive, uncontained dermal lesions was
identical in each group (Fig. 6 B). These data indicate that
both the early onset of lesion development and the exacer-
bative effect of saliva require functional lymphocytes.
Analysis of Antisaliva Antibodies in SGS-sensitized Mice and
Their Role in Neutralizing the Effects of SGS on L. major Infec-
tion and Epidermal Cytokine Responses. One explanation for
Figure 4. Two-parameter dot plots of epidermal cells of BALB/c and C57BL/6 mice stained for intracellular cytokines produced at 6 h in response to
the intradermal inoculation of PBS, or 1,000 L. major metacyclic promastigotes alone, or 1,000 metacyclics plus 0.2 pair of SGS, to naive or to SGS pre-
sensitized mice. After recovery, the epidermal cells from six ears per group, were pooled and preincubated with Brefeldin A for 6 h before being stained.
Numbers represent the percentage of cells with FL-2 signals for the particular cytokine that were greater than the background signals established using the
PE-isotype control (IgG1). The data shown are from a single experiment, representative of two separate experiments.1948 Natural Model of Cutaneous Leishmaniasis
the inability of SGS to enhance infection in mice presensi-
tized to SGS is that these animals make antisaliva antibodies
that neutralize its bioactivity. Anti-SGS antibodies in mice
immunized twice with 0.2 salivary gland equivalents were
readily detected by ELISA (data not shown). A Western
blot analysis of the serum showed four major bands recog-
nized by the serum of the immunized BALB/c and B/6
mice (Fig. 8).
To determine if the anti-SGS antibodies could neutralize
the ability of SGS to enhance infection, an IgG fraction was
prepared from immune and control sera, which were then
incubated with SGS for 10 min before addition of parasites
and intradermal injection. The antibodies present in the
SGS-sensitized mice completely abrogated the effect of
SGS on disease exacerbation in both BALB/c and B/6
mice (Fig. 9). Beginning at 2 wk, the lesions in the ears
coinoculated with either SGS or SGS preincubated with
control IgG were significantly larger (P , 0.01) than the ears
receiving either parasites alone or parasites plus SGS prein-
cubated with IgG from sensitized mice. When the SGS that
had been preincubated with IgG from immune sera was
used to elicit cytokine responses in the epidermis of naive
mice, the frequency of cells staining positive for type 2 cy-
tokines displayed a similar profile as that seen when SGS
was used to elicit epidermal responses in SGS presensitized
mice. These frequencies, along with the absolute number
of IL-4– and IL-5–producing cells per ear, are shown for
two separate experiments in Fig. 10. The antibodies from
the SGS-sensitized mice neutralized the ability of SGS to
induce IL-4 and IL-5 responses in BALB/c mice, whereas
in B/6 mice only the IL-4 response was neutralized.
Discussion
In attempts to mimic the biology of natural transmission,
we have established a model of cutaneous leishmaniasis in
the mouse that includes inoculation of low numbers of L.
major metacyclic promastigotes plus salivary gland lysates
from a natural vector, P. papatasii, into the mouse ear der-
mis. Blood sucking arthropods, including infected sand flies
capable of egesting Leishmania, will salivate into the skin in
order to locate blood and maintain its flow during inges-
tion (2). The importance of taking into account this com-
ponent of natural transmission was first addressed by Titus
and Ribeiro (8), who showed that in addition to its power-
ful antihemostatic activities, sand fly saliva will enhance the
infectivity of Leishmania. These results have since been re-
Figure 5. Total number of epidermal cells per ear producing type 2
cytokines in (A) BALB/c and (B) C57Bl/6 mice, 6 h after intradermal in-
oculation of PBS, L. major, L. major 1 SGS, and L. major 1 SGS in SGS-
sensitized mice. Data from two separate experiments are shown, deter-
mined from the two-color FACSÒ analysis of epidermal cells pooled from
6 ears per group, and calculated as the average number of epidermal cells
per ear 3 the percentage of cells staining positive for each cytokine.
Figure 6. Size of the induration of the ear lesion in (A) BALB/c wild-
type mice (s, d) or in IL-4–deficient BALB/c mice (h, j) after intra-
dermal inoculation of 1,000 metacyclic promastigotes alone (open symbols)
or with 0.2 pair of SGS (closed symbols) and in (B) BALB/c SCID mice in-
oculated with the parasite alone (s) or with 0.2 pair of SGS (d). Mean
induration in mm 6 1 SD, six to eight mice per group.1949 Belkaid et al.
inforced using diverse species of Leishmania (L. major, L.
braziliensis, and L. amazonensis) coinoculated with saliva
from two vector species (L. longipalpis and P. papatasii) (17–
19). In each case, the infection model was confined to the
evaluation of footpad lesions after subcutaneous inoculation
of parasites plus saliva. The rationale for extending these
observations to the skin is that in addition to being the tis-
sue environment in which these encounters normally oc-
cur, the skin is comprised of specialized structures and cells
that may be better adapted to respond to these insults in a
host-protective rather than a disease-promoting manner.
On the contrary, we found that the ability of SGS from P.
papatasii to exacerbate L. major infection is especially pro-
nounced in the skin. The nonhealing versus healing phe-
notypes of BALB/c versus B/6 mice, established using sub-
cutaneous sites of infection, were each maintained in the
dermal models. However, the effects of P. papatasii saliva,
which for L. major were relatively modest in the subcutane-
ous footpad infections (17), were severe in the ear dermis as
assessed by the time course of lesion appearance, the maxi-
mal size of lesion growth, and the tissue destruction associ-
ated with lesion progression. The effect in B/6 mice was
especially dramatic in that a large proportion of the dermal
lesions failed to heal for up to 8 mo after infection, an out-
come that was not observed when infections were initiated
in the footpad.
We have used this model of natural infection to intro-
duce an additional variable into the interplay between vec-
tor, parasite, and host. Since in endemic areas it is likely
that individuals at risk of exposure to infected sand flies will
have prior exposure to the bites of uninfected flies, we in-
vestigated whether preexposure to vector saliva via intra-
dermal inoculation of SGS could modify the course of L.
major infection in mice challenged with parasites plus SGS.
In both BALB/c and B/6 mice, preexposure to salivary ly-
sate completely abrogated the exacerbative effect of SGS
on the development of the dermal lesions. Two intrader-
mal injections of SGS elicited both anti-SGS antibodies and
DTH responses in these mice. Thus, there is no indication
from these studies that components in vector saliva suppress
the development of immune responses to salivary antigens,
as has been proposed (4). We were able to formally dem-
Figure 7. Size of the induration of the ear lesion in C57Bl/6 wild-type
mice (s,  d); C57Bl/6 IL-4–deficient mice (n,  m); or C57Bl/6 IL-
12p40–deficient mice (h, j) after intradermal inoculation of 1,000 meta-
cyclic promastigotes alone (open symbols) or with 0.2 pair of SGS (closed
symbols). Mean induration in mm 6 1 SD, 6–10 mice per group.
Figure 8. Western blot analy-
sis of salivary glands (1 gland per
lane) using pooled sera from un-
immunized BALB/c mice (lane
B), BALB/c mice injected intra-
dermally two times with 0.2 pair
SGS (lane C); Coomassie blue–
stained gel before transfer is
shown in lane D; molecular
weight markers are shown in
lane  A.
Figure 9. Size of the induration of the ear lesion in (A) BALB/c and
(B) C57BL/6 mice after intradermal inoculation of 1,000 metacyclic pro-
mastigotes alone (s) or with 0.2 pair of SGS saliva (d), with 0.2 pair of
SGS preincubated with serum IgG from normal mice (h), or with 0.2
pair of SGS preincubated with serum IgG from BALB/c or C57Bl/6
mice injected twice with SGS (j). Mean induration in mm 6 1 SD, six
mice per group.1950 Natural Model of Cutaneous Leishmaniasis
onstrate a role for the antisaliva antibodies in the reversal of
the salivary effect since preincubation of SGS with serum
IgG from sensitized animals completely neutralized its abil-
ity to enhance infection in both mouse strains. The results
suggest that in endemic areas, the intensity of exposure to
uninfected sand fly bites might influence the epidemiology
of cutaneous leishmaniasis. Thus, young children or indi-
viduals coming from nonendemic regions might be at
greater risk of developing more serious disease because they
are immunologically naive with respect to sand fly saliva,
not just Leishmania. So far as we are aware, no clinical stud-
ies have been undertaken to demonstrate the presence of
anti–sand fly saliva antibodies in people living in sand fly–
infested areas. Repeated bites of mosquitoes have been
shown to result in the production of antibodies against sa-
liva (22–24). Circulating antibodies against tick saliva are
produced in mice and cattle that augment complement-
mediated host resistance, expressed by reduced engorge-
ment weights and increased tick mortality, and this re-
sponse has been exploited as a means of vector control (25).
The ability of antisaliva antibodies to neutralize the bioac-
tivity of salivary components has also been demonstrated in
mice immunized by repeated bites of Anopheles stephensi
mosquitoes, which developed antibodies to apyrase that in-
hibited its catalytic activity (26). Apart from this study, only
one other experimental study has examined the presence
and effect of antisaliva antibodies in animals exposed to
sand fly bites. Hamsters exposed to Phlebotomus argentipes
bites developed high antibody titers to saliva, which ap-
peared to result in the increased mortality of flies fed on
sensitized animals (27). We have not noted any increased
mortality of sand flies fed on animals used as a repeated
source of blood meals (data not shown).
The molecule(s) present in vector saliva that are respon-
sible for the enhancement of infectivity have not been
identified. However, the finding that antibodies from sensi-
tized mice neutralize this effect should facilitate the screen-
ing of native or recombinant salivary proteins. Nonetheless,
the present studies have clarified the mechanism(s) by
which saliva might exacerbate infection. By using recently
developed methods that permit recovery of cells from the
inflammatory ear dermis, and by using intracellular staining
and flow cytometry for the first time to analyze cytokine
production by epidermal cells at the single cell level, a con-
sistent pattern of host response to sand fly saliva has
emerged. The analysis of the dermal explant cultures dur-
ing the first 48 h indicated that the steady state of the der-
mal compartment was relatively unperturbed by the intro-
duction of 1,000 parasites or parasites plus saliva. Only in
the mice presensitized with SGS did coinoculation of SGS
plus parasites produce a significant change in the recruit-
ment of cells into the dermis. The response was characteris-
tic of a DTH response; it was comprised of an influx of
eosinophils and macrophages, and it was eliminated by in
vivo treatment with anti-CD4 antibodies (data not shown).
In contrast to the dermal compartment, the epidermal re-
sponse to SGS in naive mice was early and dynamic. Flow
cytometric analyses of epidermal cells stained for intracellu-
lar cytokines in response to the tissue injury associated with
needle injection of PBS revealed a significant increase in
the frequency of cells producing IL-3, IL-5, TNF-a, IFN-g,
and MCP-1. The ability of keratinocytes, DETC, and
Langerhans’ cells to produce a wide range of cytokines in
response to tissue injury is well described (for review see
reference 20). In particular, the extremely high frequency
of cells staining for TNF-a is consistent with the ability of
keratinocytes to produce this cytokine in response to dif-
ferent epidermal exposures, including barrier disruption,
burns, UV irradiation, and TNF-a itself (28, 29). Needle
injection of 1,000 metacyclic promastigotes produced little
change in the early epidermal response profile over that
seen with PBS. In contrast, the inclusion of SGS in the low
dose inoculum elicited a consistent increase in the fre-
quency of IL-4, IL-5, and in the case of BALB/c mice,
GM-CSF–producing cells. In the only other study that has
examined the dermal cytokine response to vector saliva, in
situ hybridization was used to detect IFN-g, IL-2, and IL-4
Figure 10. Total number of epidermal cells per ear staining for selected
cytokines in (A) BALB/c and (B) C57Bl/6 mice, 6 h after intradermal in-
oculation of 1,000 metacyclic promastigotes plus 0.2 gland SGS preincu-
bated with control serum IgG (gray bars) or with serum IgG from SGS
presensitized mice (solid bars). Data from two separate experiments are
shown, determined from the two-color FACSÒ analysis of epidermal cells
pooled from six ears per group, and calculated as the average number of
epidermal cells per ear 3 the percentage of cells staining positive for each
cytokine (numbers above each bar).1951 Belkaid et al.
mRNA in mouse skin at feeding sites of Ixodes ricinus ticks
(30). Tick bites have also been shown to upregulate IL-4
production by mitogen-stimulated lymph node and spleen
cells from exposed mice (31, 32), although the systemic ef-
fects were not observed until 6–8 d after tick infestation.
In this study, the kinetics of the type 2 cytokine response
in the epidermis (6 h) suggest that components in sand fly
saliva are able to activate innate responses by DETC, which
in the mouse skin bear primarily the gd form of the antigen
receptor (33). Confirmation that these cytokines were in-
deed made by gd T cells using FACSÒ analysis of doubly
labeled cells has thus far been compromised by the poor
staining of their cell surface markers, due presumably to the
use of trypsin to recover the epidermal cells. In contrast to
acquired immunity, innate responses are not dependent on
clonally distributed receptors and MHC-restricted antigen
recognition (for review see reference 34). They can be elic-
ited instead by pattern recognition of certain types of mole-
cules common to microbial pathogens (35) and damaged or
stressed cells (36, 37). Sand fly saliva may possess a similar
class of molecules. Alternatively, the activation might be me-
diated by a pharmacologically active salivary component
(e.g., apyrase) that generates increased concentration of some
extracellular signaling molecule (e.g., AMP or adenosine).
A role for innate gd T cell responses in the regulation of
subsequent adaptive immune responses by CD41 T cells is
well described (38–40). In addition, an early burst of IL-4
produced by CD41, L. major–specific T cells controls, at
least in part, L. major susceptibility in BALB/c mice (41).
Thus, it was reasonable to suspect that the powerful effects
of saliva on disease exacerbation in the skin might be re-
lated to the early epidermal IL-4 that favored the develop-
ment of Th2 cells in the adaptive phase of the immune re-
sponse. In both BALB/c and B/6 mice, the L. major
antigen-specific IL-4 response of lymph node cells 8 wk af-
ter infection was significantly enhanced in mice infected in
the presence of SGS. Furthermore, the 6-h epidermal re-
sponse to parasites plus SGS in the mice presensitized to sa-
liva was altered primarily in the loss of cells staining for IL-4,
and their antigen-specific IL-4 response in draining nodes
8 wk after challenge returned to the levels seen in control
mice. Finally, preincubation of the SGS with antibodies
from sensitized mice, in addition to neutralizing its disease
exacerbating activity, also neutralized its ability to elicit a
rapid IL-4 response in the epidermis of naive mice.
Direct evidence that IL-4 elicited by SGS was at least
partially responsible for the enhancement of infection was
provided by the studies in IL-4–deficient BALB/c and B/6
mice, in which SGS failed in each case to significantly alter
the severity of the dermal lesions. This is consistent with a
recent report regarding the abrogation of the salivary effect
by anti–IL-4 antibodies in BALB/c mice infected with L.
braziliensis (19). Since in this L. braziliensis model lesion de-
velopment appeared to be strictly IL-4 dependent, it is pos-
sible that the saliva elicited other responses (e.g., IL-10,
TGF-b) that enhanced infection but could not be revealed
in the absence of IL-4. In contrast, IL-4 seems not to be re-
quired for the Friedlin strain of L. major to produce dermal
lesions in B/6 mice, or even for the evolution of nonheal-
ing dermal lesions in BALB/c mice, consistent with the ab-
sence of an effect of the IL-4 deletion on the growth of
certain other L. major strains in BALB/c mice (42). None-
theless, our data suggest that IL-4 upregulation by SGS can
produce an additive effect on disease exacerbation. The ab-
sence of the salivary effect in SCID mice reinforces the
likely role of T cells in mediating the exacerbation. The
finding that SGS could still exacerbate disease in the IL-
12p40 knockout mouse suggests that the effect is not
strictly due to the downregulation of a host protective Th1
response or to an ability to directly suppress IFN-g–medi-
ated activation of macrophages, as has been suggested by in
vitro experiments (3). The continued effects seen in mice
with a IFN-g–inducing defect, in addition to the sustained
effects seen in the skin long after saliva has presumably dis-
appeared from the inoculation site, emphasize the more
likely role of saliva in enhancing an adaptive Th2 response
rather than directly suppressing macrophage effector func-
tions. The Th2 cytokines elicited by SGS might further ex-
acerbate infection in mice that already have a defective
capacity for killing by promoting the recruitment of in-
flammatory cells available for infection.
In conclusion, infection of a natural tissue site, the ear
dermis, reveals an especially powerful effect on enhance-
ment of L. major infection by a key component of natural
transmission, sand fly saliva. The effect seems attributable to
the ability of saliva to elicit innate immune responses in the
skin, in particular the production of type 2 cytokines by
epidermal cells. The finding that the ability of SGS to pro-
mote infection is completely neutralized by antisaliva anti-
bodies present in mice that were previously exposed to
SGS has important implications regarding the epidemiol-
ogy of leishmanial disease, and validates the prior sugges-
tion (17) that salivary molecules might be effective compo-
nents of an anti–L. major vaccine.
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